Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

DECISION+, a Training Program to Improve Optimal Drug Prescription (Decision+)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
France Legare, Centre Hospitalier Universitaire de Québec, CHU de Québec
ClinicalTrials.gov Identifier:
NCT01116076
First received: May 3, 2010
Last updated: January 30, 2013
Last verified: January 2013